Item Type | Name |
Academic Article
|
In vivo susceptibility of Campylobacter pylori.
|
Academic Article
|
Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C urea breath test.
|
Academic Article
|
Resolution of a metaplastic duodenal polyp after cure of Helicobacter pylori infection.
|
Academic Article
|
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
|
Academic Article
|
Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole.
|
Academic Article
|
Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular?
|
Academic Article
|
Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy.
|
Academic Article
|
Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria.
|
Academic Article
|
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates.
|
Academic Article
|
Helicobacter pylori.
|
Academic Article
|
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection.
|
Academic Article
|
Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States.
|
Academic Article
|
Diagnosis and management of Helicobacter pylori infection.
|
Academic Article
|
Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection.
|
Academic Article
|
Update on Helicobacter pylori research. Eradication.
|
Academic Article
|
Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
|
Academic Article
|
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea.
|
Academic Article
|
Decrease in gastric permeability to sucrose following cure of Helicobacter pylori infection.
|
Academic Article
|
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.
|
Academic Article
|
Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States.
|
Academic Article
|
Amoxycillin tolerance in Helicobacter pylori.
|
Academic Article
|
Challenge model for Helicobacter pylori infection in human volunteers.
|
Academic Article
|
Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.
|
Academic Article
|
Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori.
|
Academic Article
|
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan.
|
Academic Article
|
Frame-shift mutations in NAD(P)H flavin oxidoreductase encoding gene (frxA) from metronidazole resistant Helicobacter pylori ATCC43504 and its involvement in metronidazole resistance.
|
Academic Article
|
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.
|
Academic Article
|
Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border.
|
Academic Article
|
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
|
Academic Article
|
One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm.
|
Academic Article
|
CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection.
|
Academic Article
|
Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States.
|
Academic Article
|
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
|
Academic Article
|
Double-blind randomized trial of quadruple sequential Helicobacter pylori eradication therapy in asymptomatic infected children in El Paso, Texas.
|
Academic Article
|
Natural history of gastric cancer after Helicobacter pylori eradication in Japan: after endoscopic resection, after treatment of the general population, and naturally.
|
Academic Article
|
Helicobacter pylori eradication and its effect on iron stores: a reappraisal.
|
Academic Article
|
Treatment of Helicobacter pylori in Latin America.
|
Academic Article
|
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.
|
Academic Article
|
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
|
Academic Article
|
Ulcers and gastritis.
|
Academic Article
|
Adherence, internalization, and persistence of Helicobacter pylori in hepatocytes.
|
Academic Article
|
A report card to grade Helicobacter pylori therapy.
|
Academic Article
|
New concepts of resistance in the treatment of Helicobacter pylori infections.
|
Academic Article
|
Efficient identification and evaluation of effective Helicobacter pylori therapies.
|
Academic Article
|
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication.
|
Academic Article
|
Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.
|
Academic Article
|
OLGA can guard the barn.
|
Academic Article
|
Clinical practice: diagnosis and evaluation of dyspepsia.
|
Academic Article
|
Helicobacter pylori treatment in the era of increasing antibiotic resistance.
|
Academic Article
|
Addition of gentamicin to endoscopic retrograde cholangiopancreatography (ERCP) contrast medium towards reducing the frequency of septic complications of ERCP.
|
Academic Article
|
Understanding and appreciating sequential therapy for Helicobacter pylori eradication.
|
Academic Article
|
Helicobacter pylori eradication therapy research: Ethical issues and description of results.
|
Academic Article
|
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study.
|
Academic Article
|
Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
|
Academic Article
|
Which Therapy for Helicobacter pylori Infection?
|
Academic Article
|
Empiric therapies for Helicobacter pylori infections.
|
Academic Article
|
Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days.
|
Academic Article
|
Guide regarding choice of second-line therapy to obtain a high cumulative cure rate.
|
Academic Article
|
Helicobacter pylori: tailored therapy with novel sequential quadruple therapies.
|
Academic Article
|
Clinical impact of stool cultures for Campylobacter in adults with acute or chronic diarrhea.
|
Academic Article
|
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance.
|
Academic Article
|
Twenty-minute fasting version of the US 13C-urea breath test for the diagnosis of H. pylori infection.
|
Academic Article
|
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
|
Academic Article
|
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach.
|
Academic Article
|
Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study.
|
Academic Article
|
Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen.
|
Academic Article
|
Ethical considerations of comparing sequential and traditional anti Helicobacter pylori therapy.
|
Academic Article
|
Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.
|
Academic Article
|
Helicobacter pylori eradication and change in markers of iron stores among non-iron-deficient children in El Paso, Texas: an etiologic intervention study.
|
Concept
|
Anti-Bacterial Agents
|
Academic Article
|
Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China.
|
Academic Article
|
Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection.
|
Academic Article
|
Helicobacter pylori research: historical insights and future directions.
|
Academic Article
|
Helicobacter pylori therapy demystified.
|
Academic Article
|
Helicobacter pylori diagnosis and management.
|
Academic Article
|
Clarithromycin for Helicobacter pylori infection.
|
Academic Article
|
Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics.
|
Academic Article
|
Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogot? D.C., Colombia.
|
Academic Article
|
Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies.
|
Academic Article
|
Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.
|
Academic Article
|
Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?
|
Academic Article
|
Helicobacter pylori infection: diagnosis and treatment.
|
Academic Article
|
Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy.
|
Academic Article
|
Helicobacter pylori infection.
|
Academic Article
|
Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.
|
Academic Article
|
Helicobacter pylori eradication and metachronous gastric cancer.
|
Academic Article
|
Evidence-based recommendations for successful Helicobacter pylori treatment.
|
Academic Article
|
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate.
|
Academic Article
|
Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests.
|
Academic Article
|
Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance.
|
Academic Article
|
High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections.
|
Academic Article
|
Metachronous gastric cancer after successful Helicobacter pylori eradication.
|
Academic Article
|
RE: Effects of helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups.
|
Academic Article
|
Improved allele-specific PCR assays for detection of clarithromycin and fluoroquinolone resistant of Helicobacter pylori in gastric biopsies: identification of N87I mutation in GyrA.
|
Academic Article
|
Editorial: quadruple therapy for H. pylori eradication is better than triple therapy - authors' reply.
|
Academic Article
|
Roadmap for elimination of gastric cancer in Korea.
|
Academic Article
|
Helicobacter pylori infection in India from a western perspective.
|
Academic Article
|
Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.
|
Academic Article
|
Letter: bismuth, levofloxacin, amoxicillin, PPI quadruple therapy is not an effective first or second line regimen in the presence of levofloxacin resistance.
|
Academic Article
|
Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans.
|
Academic Article
|
Kyoto global consensus report on Helicobacter pylori gastritis.
|
Academic Article
|
Letter: clarithromycin dose for H.?pylori therapy remains unresolved.
|
Academic Article
|
How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.
|
Academic Article
|
Helicobacter pylori: New Thoughts and Practices.
|
Academic Article
|
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
|
Academic Article
|
Mycobacterium paratuberculosis as a cause of Crohn's disease.
|
Academic Article
|
Hybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis.
|
Academic Article
|
Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype.
|
Academic Article
|
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
|
Academic Article
|
Role of bismuth in improving Helicobacter pylori eradication with triple therapy.
|
Academic Article
|
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
|
Academic Article
|
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
|
Academic Article
|
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues.
|
Academic Article
|
Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.
|
Academic Article
|
Helicobacter pylori infection and antibiotic resistance: a WHO high priority?
|
Academic Article
|
It is time to rethink H. pylori therapy.
|
Academic Article
|
Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogot?-Colombia (2009-2014).
|
Academic Article
|
Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.
|
Academic Article
|
Illusions regarding Helicobacter pylori clinical trials and treatment guidelines.
|
Academic Article
|
Helicobacter pylori management in ASEAN: The Bangkok consensus report.
|
Academic Article
|
Editorial: recurrence of Helicobacter pylori infection-still the same after all these years? Authors' reply.
|
Academic Article
|
Update on the Use of Vonoprazan: A Competitive Acid Blocker.
|
Academic Article
|
Brief report: Lactobacillus bulgaricus GLB44 (Proviotic? ) plus esomeprazole for Helicobacter pylori eradication: A pilot study.
|
Academic Article
|
Lessons From Using Culture-Guided Treatment After Referral for Multiple Treatment Failures for Helicobacter pylori Infection.
|
Academic Article
|
Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial.
|
Academic Article
|
Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies.
|
Academic Article
|
Optimizing first line 7-day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better?
|
Academic Article
|
The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal.
|
Academic Article
|
Current and Future Treatment of Helicobacter pylori Infections.
|
Academic Article
|
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment.
|
Academic Article
|
High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial.
|
Academic Article
|
Editorial: not yet time for universal susceptibility-guided first-line Helicobacter pylori treatment-authors' reply.
|
Academic Article
|
Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera? or Lactobacillus reuteri for treatment na?ve or for retreatment of Helicobacter pylori. Two randomized pilot studies.
|
Academic Article
|
14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment.
|
Academic Article
|
PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis.
|
Academic Article
|
Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial.
|
Academic Article
|
Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands.
|
Academic Article
|
European Registry on Helicobacter pylori management shows that gastroenterology has largely failed in its efforts to guide practitioners.
|
Academic Article
|
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.
|
Academic Article
|
Is there a role for sequential in sequential anti-H. pylori therapy?
|
Academic Article
|
The QUADRATE study: a proposal for a change in the reporting of pharmaceutical supported trials.
|
Academic Article
|
Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapy.
|
Academic Article
|
Recent Developments Pertaining to H. pylori Infection.
|
Academic Article
|
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study.
|
Academic Article
|
Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship.
|
Academic Article
|
National and Regional US Antibiotic Resistance to Helicobacter pylori: Lessons From a Clinical Trial.
|
Academic Article
|
Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis.
|
Academic Article
|
Comparison of Culture With Antibiogram to Next-Generation Sequencing Using Bacterial Isolates and Formalin-Fixed, Paraffin-Embedded Gastric Biopsies.
|
Academic Article
|
Cross-roads for meta-analysis and network meta-analysis of H. pylori therapy.
|
Academic Article
|
Diagnosis and Treatment of Helicobacter pylori Infection.
|
Academic Article
|
Comparable Results of Helicobacter pylori Antibiotic Resistance Testing of Stools vs Gastric Biopsies Using Next-Generation Sequencing.
|
Academic Article
|
Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why.
|
Academic Article
|
Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe.
|
Academic Article
|
How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities.
|
Academic Article
|
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study.
|
Academic Article
|
Response to: a true point-of-care molecular testing method for tailored therapy for Helicobacter pylori eradication.
|
Academic Article
|
Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates.
|
Academic Article
|
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial.
|
Academic Article
|
It Is Time for a Paradigm Shift in Design, Execution, and Publishing of Comparative Helicobacter pylori Treatment Trials.
|
Academic Article
|
Eradicating Helicobacter pylori via 13C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
|
Academic Article
|
Pilot studies of vonoprazan-containing Helicobacter pylori eradication therapy suggest Thailand may be more similar to the US than Japan.
|
Academic Article
|
Toward Quantification of H pylori-associated Gastric Cancer Risk: Further Evidence Supporting Development of Population-based Strategies for H pylori Eradication.
|
Academic Article
|
A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran.
|